Acute lymphoblastic leukemia screening: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
(Category) |
||
Line 16: | Line 16: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Revision as of 01:50, 24 October 2017
Acute lymphoblastic leukemia Microchapters |
Differentiating Acute lymphoblastic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute lymphoblastic leukemia screening On the Web |
American Roentgen Ray Society Images of Acute lymphoblastic leukemia screening |
Directions to Hospitals Treating Acute lymphoblastic leukemia |
Risk calculators and risk factors for Acute lymphoblastic leukemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3]
Overview
According to the National cancer institute, screening for acute lymphoblastic leukemia is not recommended.[1]
Acute lymphoblastic leukemia screening
According to the National cancer institute, screening for acute lymphoblastic leukemia is not recommended.[1]